Loading…
avatar for Hari Subramanian

Hari Subramanian

NanoCytomics
Co-Founder and Chief Technology Officer

Dr. Subramanian is a Co-founder and Chief Technology Officer of NanoCytomics (www.nano-cytomics.com), an in vitro medical diagnostic company developing screening strategies for different types of cancers (e.g, lung, colon, prostate etc). He is also a Research Professor of Biomedical Engineering at Northwestern University. Dr. Subramanian was one of the original developers of partial wave spectroscopic (PWS) microscopy, the company’s foundational technology platform. He is currently spearheading the NanoCytomics clinical implementation of the technology for risk-stratification applications in colon, lung, prostate, esophageal, ovarian and pancreatic cancers. Dr. Subramanian has considerable experience in the areas of biomedical optics, cancer biology and clinical research, with numerous publications appearing in leading peer-reviewed journals. Dr. Subramanian has received multiple research and business challenge awards, and he serves as a technical reviewer for several scientific and medical journals. He received his PhD in biomedical engineering from Northwestern University.

My Speakers Sessions

Tuesday, October 3
 

10:15am